nach oben

Current Oncology Reports

Erschienen in:

01.01.2015 | Head and Neck Cancers (E Hanna, Section Editor)

Defining Value-Driven Care in Head and Neck Oncology

verfasst von: Benjamin R. Roman, Mahmoud I. Awad, Snehal G. Patel

Erschienen in: Current Oncology Reports | Ausgabe 1/2015

Einloggen, um Zugang zu erhalten

Abstract

In the USA, increasing attention is being paid to adopting a value-based framework for measuring and ultimately improving health care delivery. Value is defined as the benefit achieved relative to costs. The numerator of the value equation includes quality of care and outcomes achieved. The denominator includes costs, both financial costs and harms of treatment. Herein, we describe these elements of value as they pertain to head and neck cancer. A particular focus is to identify areas of the value equation where physicians have some control. We examine quality in each of three dimensions: structure, process, and outcomes. We also adopt Porter’s three-tiered hierarchy of outcomes model, with specific outcomes relevant to patients with head and neck and thyroid cancer. Finally, we review issues related to costs and harms. We believe these findings can serve as a framework for further efforts to drive value-based delivery of head and neck cancer care.

1.••

Porter ME. What is value in health care? N Engl J Med. 2010;363(26):2477–81. Perspective piece that describes the value framework in health care and outlines the outcome measures hierarchy.PubMedCrossRef

PCORI. Patient Centered Outcomes Research Institute, Mission & vision. May 13, 2014]; Available from: http://www.pcori.org/about-us/mission-and-vision/.

Institute of Medicine. Best care at lower cost: the path to continuously learning health care in America. Washington, DC: National Academy Press; 2012.

Institute of Medicine. The healthcare imperative: lowering costs and improving outcomes. Washington, DC: National Academies Press; 2010.

Cassel CK, Guest JA. Choosing wisely: helping physicians and patients make smart decisions about their care. JAMA. 2012;307(17):1801–2.PubMedCrossRef

6.••

Choosing Wisely Campaign. 2013 May 10, 2013]; Available from: http://www.choosingwisely.org. Website of the Choosing Wisely Campaign with society-specific lists of overused or unnecessary medical services.

Institute of Medicine. Delivering affordable cancer care in the 21st century: workshop summary. Washington, DC: National Academies Press; 2013.

8.••

Institute of Medicine. Delivering high-quality cancer care: charting a new course for a system in crisis. Washington, DC: National Academies Press; 2013. Critical appraisal of the quality of cancer care in the USA and recommendations for improvement by the IOM.

Keehan SP et al. National health spending projections through 2020: economic recovery and reform drive faster spending growth. Health Aff (Millwood). 2011;30(8):1594–605.CrossRef

10.

Auerbach DI, Kellermann AL. A decade of health care cost growth has wiped out real income gains for an average US family. Health Aff (Millwood). 2011;30(9):1630–6.CrossRef

11.

Kaiser Family Foundation. Health spending: trends and impact. 2014. Available from: http://kff.org/slideshow/health-spending-trends-and-impact/

12.

Institute of Medicine. Crossing the quality chasm: a new health system for the 21st century. Washington, DC: National Academy Press; 2001.

13.

Institute of Medicine. To err is human: building a safer health system. Washington, DC: National Academy Press; 1999.

14.

Donabedian A. The quality of care. How can it be assessed? JAMA. 1988;260:1743–8.PubMedCrossRef

15.

Gourin CG, Frick KD. National trends in laryngeal cancer surgery and the effect of surgeon and hospital volume on short-term outcomes and cost of care. 2012(January): p. 88–94.

16.

Gourin CG, Frick KD. National trends in oropharyngeal cancer surgery and the effect of surgeon and hospital volume on short-term outcomes and cost of care. Laryngoscope. 2012;122(3):543–51.PubMedCrossRef

17.

Gourin CG et al. Impact of surgeon and hospital volume on short-term outcomes and cost of laryngeal cancer surgical care. Laryngoscope. 2011;121(1):85–90.PubMedCrossRef

18.

Gourin CG et al. Impact of surgeon and hospital volume on short-term outcomes and cost of oropharyngeal cancer surgical care. Laryngoscope. 2011;121(4):746–52.PubMedCentralPubMedCrossRef

19.

Chen AY et al. Impact of treating facilities’ volume on survival for early-stage laryngeal cancer. Head Neck. 2009;31(9):1137–43.PubMedCrossRef

20.

Chen AY et al. Improved survival is associated with treatment at high-volume teaching facilities for patients with advanced stage laryngeal cancer. Cancer. 2010;116(20):4744–52.PubMedCrossRef

21.

Cheung MC et al. Impact of hospital volume on surgical outcome for head and neck cancer. Ann Surg Oncol. 2009;16(4):1001–9.PubMedCrossRef

22.

Jeannon JP et al. Implementing the national institute of clinical excellence improving outcome guidelines for head and neck cancer: developing a business plan with reorganisation of head and neck cancer services. Clin Otolaryngol. 2008;33(2):149–51.PubMedCrossRef

23.

Gourin CG et al. Volume-based trends in laryngeal cancer surgery. Laryngoscope. 2011;121(1):77–84.PubMedCrossRef

24.

Gourin CG et al. Volume-based trends in surgical care of patients with oropharyngeal cancer. Laryngoscope. 2011;121(4):738–45.PubMedCrossRef

25.•

Lewis CM et al. Prereferral head and neck cancer treatment: compliance with national comprehensive cancer network treatment guidelines. Arch Otolaryngol Head Neck Surg. 2010;136(12):1205–11. The study analyzed compliance to NCCN guidelines prior to referral to a tertiary care center.PubMedCrossRef

26.

Roman BR, et al. The 2009 American Thyroid Association guidelines modestly reduced radioactive iodine use for thyroid cancers less than 1 cm. Thyroid. 2014;24(10):1549-50

27.

Roman BR, et al. Guideline familiarity predicts variation in self-reported use of routine surveillance PET/CT by physicians who treat head and neck cancer. J NCCN, in press, 2014.

28.•

Roman BR, Feingold J. Patient-centered guideline development: best practices can improve the quality and impact of guidelines. Otolaryngol Head Neck Surg. 2014;15(4):530-532 This article emphasizes the role that guideline development plays in patient-centered care and the role that patients can play in guideline development.

29.

Ouwens MM et al. Quality of integrated care for patients with head and neck cancer: development and measurement of clinical indicators. Head Neck. 2007;29(4):378–86.PubMedCrossRef

30.

Ouwens MMTJ et al. Impact of an integrated care program for patients with head and neck cancer on the quality of care. Head Neck. 2009;31(7):902–10.PubMedCrossRef

31.

Kelly SL et al. Multidisciplinary clinic care improves adherence to best practice in head and neck cancer. Am J Otolaryngol. 2013;34(1):57–60.PubMedCrossRef

32.

Friedland PL et al. Impact of multidisciplinary team management in head and neck cancer patients. Br J Cancer. 2011;104(8):1246–8.PubMedCentralPubMedCrossRef

33.

Husbands JM et al. Clinical care pathways: decreasing resource utilization in head and neck surgical patients. Otolaryngol Head Neck Surg. 1999;121(6):755–9.PubMedCrossRef

34.

Chen AY et al. The impact of clinical pathways on the practice of head and neck oncologic surgery: the University of Texas M. D. Anderson cancer center experience. Arch Otolaryngol Head Neck Surg. 2000;126(3):322–6.PubMedCrossRef

35.

Chalian AA et al. Design and impact of intraoperative pathways for head and neck resection and reconstruction. Arch Otolaryngol Head Neck Surg. 2002;128(8):892–6.PubMedCrossRef

36.

Khuri SF et al. The Department of Veterans Affairs’ NSQIP: the first national, validated, outcome-based, risk-adjusted, and peer-controlled program for the measurement and enhancement of the quality of surgical care. National VA surgical quality improvement program. Ann Surg. 1998;228(4):491–507.PubMedCentralPubMedCrossRef

37.

Lawson EH et al. A comparison of clinical registry versus administrative claims data for reporting of 30-day surgical complications. Ann Surg. 2012;256(6):973–81.PubMedCrossRef

38.

Awad MI, et al. Accuracy of administrative and clinical registry data in reporting postoperative complications after surgery for oral cavity squamous cell carcinoma. Head & Neck, 2014. Epub ahead of print.

39.

Clark RE. The development of the society of thoracic surgeons voluntary national database system: genesis, issues, growth, and status. Best Pract Benchmark Healthc. 1996;1(2):62–9.

40.

Porter ME. Measuring health outcomes: the outcome hierarchy. Online Supplementary Appendix 2 to What is value in health care? N Engl J Med. 2010;363(26):2477–81

41.

Porter ME. Value in health care. Online Supplementary Appendix 1 to What is value in health care? N Engl J Med. 2010;363(26):2477–81

42.

Rogers SN et al. The addition of mood and anxiety domains to the University of Washington quality of life scale. Head Neck. 2002;24(6):521–9.PubMedCrossRef

43.

Chen AY et al. The development and validation of a dysphagia-specific quality-of-life questionnaire for patients with head and neck cancer: the M. D. Anderson dysphagia inventory. Arch Otolaryngol Head Neck Surg. 2001;127(7):870–6.PubMed

44.

Schwartz SR, McDowell J, Yueh B. Numeracy and the shortcomings of utility assessment in head and neck cancer patients. Head Neck. 2004;26(5):401–7.PubMedCrossRef

45.•

Tschiesner U et al. Development of ICF core sets for head and neck cancer. Head Neck. 2010;32(2):210–20. This article represents the first version of head and neck cancer-specific ICF core set.PubMed

46.

Leib A, Cieza A, Tschiesner U. Perspective of physicians within a multidisciplinary team: content validation of the comprehensive ICF core set for head and neck cancer. Head Neck. 2012;34(7):956–66.PubMedCrossRef

47.••

Patel SG, Lydiatt WM. Staging of head and neck cancers: is it time to change the balance between the ideal and the practical? J Surg Oncol. 2008;97(8):653–7. This article describes the limitations of traditional cancer staging systems and suggests a role for novel computational technology for prognostication.PubMedCrossRef

48.

Ali S et al. A predictive nomogram for recurrence of carcinoma of the major salivary glands. JAMA Otolaryngol Head Neck Surg. 2013;139(7):698–705.PubMed

49.

Ali S et al. Postoperative nomograms predictive of survival after surgical management of malignant tumors of the major salivary glands. Ann Surg Oncol. 2014;21(2):637–42.PubMedCrossRef

50.

Montero PH, et al., Individualized outcome prediction following surgery for oral cancer. Oral presentation at 5TH World Congress of IFHNOS/2014 AHNS Annual Meeting, 2014.

51.

Montero PH et al. Nomograms for preoperative prediction of prognosis in patients with oral cavity squamous cell carcinoma. Cancer. 2014;120(2):214–21.PubMedCrossRef

52.

Gross ND et al. Nomogram for deciding adjuvant treatment after surgery for oral cavity squamous cell carcinoma. Head Neck. 2008;30(10):1352–60.PubMedCrossRef

53.

Wang SJ et al. An oral cavity carcinoma nomogram to predict benefit of adjuvant radiotherapy. JAMA Otolaryngol Head Neck Surg. 2013;139(6):554–9.PubMedCrossRef

54.

Nixon IJ et al. Nomogram for predicting malignancy in thyroid nodules using clinical, biochemical, ultrasonographic, and cytologic features. Surgery. 2010;148(6):1120–7. discussion 1127–8.PubMedCrossRef

55.

Nixon IJ et al. Nomogram for selecting thyroid nodules for ultrasound-guided fine-needle aspiration biopsy based on a quantification of risk of malignancy. Head Neck. 2013;35(7):1022–5.PubMedCrossRef

56.

Ali S et al. Nomogram to aid selection of patients for short-stay thyroidectomy based on risk of postoperative hypocalcemia. Arch Otolaryngol Head Neck Surg. 2011;137(11):1154–60.PubMedCrossRef

57.

Awad MI, et al. Individualized risk estimation of postoperative complications following surgery for oral cavity squamous cell carcinoma. Oral presentation at 5TH World Congress of IFHNOS/2014 AHNS Annual Meeting.

58.

Berwick DM, Hackbarth AD. Eliminating waste in US. Health Care. 2012;307(14):1513–6.

59.

Roman, BR, Asch DA. Faded promises: the challenge of deadopting low-value care. Annals of Internal Medicine. 2014;15:161(2):149-50

60.

Smith TJ, Hillner BE. Bending the cost curve in cancer care. N Engl J Med. 2011;364(21):2060–5.PubMedCentralPubMedCrossRef

61.

Davies L, Welch HG. Increasing incidence of thyroid cancer in the United States, 1973–2002. JAMA. 2006;295(18):2164–7.PubMedCrossRef

62.••

Morris LG, et al. The increasing incidence of thyroid cancer: the influence of access to care. Thyroid. 2013;23(7):885-891. Using SEER data, this article concludes that overdiagnosis of thyroid cancer is occurring by providing evidence for an association with access to health care.

63.

Haymart MR et al. Use of radioactive iodine for thyroid cancer. JAMA. 2011;306(7):721–8.

64.

Cooper DS et al. Revised American Thyroid Association management guidelines for patients with thyroid nodules and differentiated thyroid cancer. Thyroid. 2009;19(11):1167–214.PubMedCrossRef

65.

Kurien G et al. Cost-effectiveness of positron emission tomography / computed tomography in the management of advanced head and neck cancer. J Otolaryngol Head Neck Surg. 2011;40(6):468–72.PubMed

66.

Rabalais A, et al. A cost-effectiveness analysis of positron emission tomography-computed tomography surveillance versus up-front neck dissection for management of the neck for N2 disease after chemoradiotherapy. The Laryngoscope. 2012;122(2):311-314.

67.

Sher DJ, et al. Cost-effectiveness of CT and PET-CT for determining the need for adjuvant neck dissection in locally advanced head and neck cancer. Annals of oncology. 2010;21(5):1072-1077.

68.

Pryor DI, et al. Economic analysis of FDG-PET-guided management of the neck after primary chemoradiotherapy for node-positive head and neck squamous cell carcinoma. Head Neck. 2013;35(9):1287-1294.

69.

Higgins KM. What treatment for early-stage glottic carcinoma among adult patients: CO2 endolaryngeal laser excision versus standard fractionated external beam radiation is superior in terms of cost utility? Laryngoscope. 2011;121(1):116–34.PubMedCrossRef

70.

Davis GE et al. Cost comparison of surgery vs organ preservation for laryngeal cancer. Arch Otolaryngol Head Neck Surg. 2005;131(1):21–6.PubMedCrossRef

71.

Shrime MG et al. Cost-effective management of low-risk papillary thyroid carcinoma. Arch Otolaryngol Head Neck Surg. 2007;133(12):1245–53.PubMedCrossRef

72.•

Mathias JS, Baker DW. Developing quality measures to address overuse. JAMA. 2013;309(18):1897–8. This piece highlights the potential role for overuse measures in containing costs in the US health care system.PubMedCrossRef

73.

Lakdawalla DN et al. How cancer patients value hope and the implications for cost-effectiveness assessments of high-cost cancer therapies. Health Aff (Millwood). 2012;31(4):676–82.CrossRef

74.••

Feeley TW et al. A method for defining value in healthcare using cancer care as a model. J Healthc Manag / Am Coll Healthcare Executives. 2010;55(6):399–411. discussion 411–2. An application of the value framework to a multidisciplinary care center that treats head and neck cancers with a view to define and measure outcomes and costs.

75.

Kaplan RS, Anderson SR. Time-driven activity-based costing. Harv Bus Rev. 2004;82(11):131–40.PubMed

76.

Asch DA, Volpp KG. What business are we in? The emergence of health as the business of health care. N Engl J Med. 2012;367(10):888–9.PubMedCrossRef

Titel: Defining Value-Driven Care in Head and Neck Oncology
verfasst von: Benjamin R. Roman
Mahmoud I. Awad
Snehal G. Patel
Publikationsdatum: 01.01.2015
Verlag: Springer US
Erschienen in: Current Oncology Reports / Ausgabe 1/2015
Print ISSN: 1523-3790
Elektronische ISSN: 1534-6269
DOI: https://doi.org/10.1007/s11912-014-0424-y

Klimawandel und Gesundheit: Was Sie in der Hausarztpraxis wissen müssen und tun können

Springer Medizin

Defining Value-Driven Care in Head and Neck Oncology

Abstract

Neu im Fachgebiet Onkologie

Alter verschlechtert Prognose bei Endometriumkarzinom

Darf man die Behandlung eines Neonazis ablehnen?

Erhöhte Mortalität bei postpartalem Brustkrebs

Hypertherme Chemotherapie bietet Chance auf Blasenerhalt

Update Onkologie

Klimawandel und Gesundheit: Was Sie in der Hausarztpraxis wissen müssen und tun können

Springer Medizin

Abstract

Bitte loggen Sie sich ein, um Zugang zu diesem Inhalt zu erhalten

Weitere Artikel der Ausgabe 1/2015

Endoscopic Approaches for Early-Stage Esophageal Cancer: Current Options

Update on Treatment of Liver Metastases: Focus on Ablation Therapies

Prognosis and Biology in Esthesioneuroblastoma: the Emerging Role of Hyams Grading System

Body Image: a Critical Psychosocial Issue for Patients With Head and Neck Cancer

Intraoperative Radiotherapy for Gastrointestinal Malignancies: Contemporary Outcomes With Multimodality Therapy

Neu im Fachgebiet Onkologie

Alter verschlechtert Prognose bei Endometriumkarzinom

Darf man die Behandlung eines Neonazis ablehnen?

Erhöhte Mortalität bei postpartalem Brustkrebs

Hypertherme Chemotherapie bietet Chance auf Blasenerhalt

Update Onkologie